About the Study
The purpose of this research is to test a new investigational vaccine, VAX-31. VAX-31 causes the body to make antibodies (germ fighters) in adults who previously received a pneumococcal vaccine, and potentially increases the amount of antibodies to the strains in common with the previous pneumococcal vaccine.


